NCT00428077 2011-09-02
Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
OHSU Knight Cancer Institute
Phase 2 Terminated
Clinical Trials
1 trialsTerminated × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Reverse Transcriptase Polymerase Chain Reaction × Clear all